Clinical Trial Update: ICVAX as a HIV Therapeutic DNA Vaccine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ICVAX, an HIV therapeutic DNA vaccine, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ICVAX (HIV therapeutic DNA vaccine)

Snippet

Sponsor: Immuno Cure Holding (HK) Limited | Conditions: Human Immunodeficiency Virus, Human Immunodeficiency Virus I Infection | Phase 1 | Status: COMPLETED